SEBI: Restrains Sterling Biotech's Directors, MD from market, for devising fraudulent GDRs scheme
Jul 06, 2021
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals